Bispecific PD1-IL2v and anti-PD-L1 break tumor immunity resistance by enhancing stem-like tumor-reactive CD8+ T cells and reprogramming macrophages
双特异性 PD1-IL2v 和抗 PD-L1 通过增强干细胞样肿瘤反应性 CD8+ T 细胞和重编程巨噬细胞来打破肿瘤免疫抵抗
期刊:Immunity
影响因子:25.5
doi:10.1016/j.immuni.2022.12.006
Mélanie Tichet, Stephan Wullschleger, Agnieszka Chryplewicz, Nadine Fournier, Rachel Marcone, Annamaria Kauzlaric, Krisztian Homicsko, Laura Codarri Deak, Pablo Umaña, Christian Klein, Douglas Hanahan
